NCT02032277 arm group 8eea6d07f9e2964aafa6da6c853c457e [clinicaltrials_resource:NCT02032277/arm-group/8eea6d07f9e2964aafa6da6c853c457e]
Paclitaxel [clinicaltrials_resource:2faf0231045589a666cbf07e1855164d]Placebo [clinicaltrials_resource:57f05d51eff59a581cd69c9f2a793530]Doxorubicin [clinicaltrials_resource:675e17967a0b31eb9364aaa390d78cca]Carboplatin [clinicaltrials_resource:89da5ff05cc21db6a5e861d95217cc07]Cyclophosphamide [clinicaltrials_resource:f6a469432f61a625d08d86724ed958a1]clinicaltrials:NCT02032277
arm group [clinicaltrials_vocabulary:arm-group]
NCT02032277 arm group 8eea6d07f9e2964aafa6da6c853c457e [clinicaltrials_resource:NCT02032277/arm-group/8eea6d07f9e2964aafa6da6c853c457e]
Bio2RDF identifier
NCT02032277/arm-group/8eea6d07f9e2964aafa6da6c853c457e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... ea6d07f9e2964aafa6da6c853c457e
description [clinicaltrials_vocabulary:description]
Placebo + carboplatin + paclitaxel followed by AC
identifier
clinicaltrials_resource:NCT02032277/arm-group/8eea6d07f9e2964aafa6da6c853c457e
title
NCT02032277 arm group 8eea6d07f9e2964aafa6da6c853c457e
@en
type
label
NCT02032277 arm group 8eea6d07 ...... a6d07f9e2964aafa6da6c853c457e]
@en